ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Ennogen Investments Ltd

Ennogen Investments Ltd is an active company incorporated on 15 March 2021 with the registered office located in Dartford, Kent. Ennogen Investments Ltd was registered 4 years ago.
Status
Active
Active since 3 years ago
Company No
13266253
Private limited company
Age
4 years
Incorporated 15 March 2021
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 14 March 2025 (9 months ago)
Next confirmation dated 14 March 2026
Due by 28 March 2026 (2 months remaining)
Last change occurred 1 year 8 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Audit Exemption Subsidiary
Next accounts for period 31 December 2025
Due by 30 September 2026 (9 months remaining)
Contact
Address
Unit G4
Riverside Way
Dartford
DA1 5BS
England
Same address since incorporation
Telephone
Unreported
Email
Unreported
People
Officers
2
Shareholders
11
Controllers (PSC)
1
Director • Chartered Accountants • English • Lives in United Arab Emirates • Born in May 1976
Director • Pharmacist • British • Lives in UK • Born in Jul 1960
Ennogen Holdings Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Ennogen Healthcare International Limited
Gurdev Singh Ruprai and Jason Rodney Tate are mutual people.
Active
Ennogen Ip Ltd
Gurdev Singh Ruprai and Jason Rodney Tate are mutual people.
Active
Inventica Investments Ltd
Gurdev Singh Ruprai is a mutual person.
Active
Ennogen Pharma Ltd
Gurdev Singh Ruprai is a mutual person.
Active
Ennogen Healthcare Ltd
Gurdev Singh Ruprai is a mutual person.
Active
Pharmpact Ltd
Gurdev Singh Ruprai is a mutual person.
Active
Vitame Ltd
Gurdev Singh Ruprai is a mutual person.
Active
GB Investec UK Limited
Gurdev Singh Ruprai is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£46K
Increased by £45K (+4500%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£71.65M
Increased by £133K (0%)
Total Liabilities
-£66K
Increased by £57K (+633%)
Net Assets
£71.58M
Increased by £76K (0%)
Debt Ratio (%)
0%
Increased by 0.08% (+632%)
Latest Activity
Subsidiary Accounts Submitted
1 Month Ago on 10 Nov 2025
Jason Rodney Tate Details Changed
2 Months Ago on 15 Oct 2025
Charge Satisfied
5 Months Ago on 22 Jul 2025
Charge Satisfied
5 Months Ago on 22 Jul 2025
New Charge Registered
5 Months Ago on 17 Jul 2025
New Charge Registered
5 Months Ago on 17 Jul 2025
Confirmation Submitted
9 Months Ago on 4 Apr 2025
Subsidiary Accounts Submitted
1 Year Ago on 5 Dec 2024
New Charge Registered
1 Year 8 Months Ago on 16 Apr 2024
New Charge Registered
1 Year 8 Months Ago on 16 Apr 2024
Get Credit Report
Discover Ennogen Investments Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Audit exemption subsidiary accounts made up to 31 December 2024
Submitted on 10 Nov 2025
Director's details changed for Jason Rodney Tate on 15 October 2025
Submitted on 28 Oct 2025
Notice of agreement to exemption from audit of accounts for period ending 31/12/24
Submitted on 15 Oct 2025
Audit exemption statement of guarantee by parent company for period ending 31/12/24
Submitted on 15 Oct 2025
Consolidated accounts of parent company for subsidiary company period ending 31/12/24
Submitted on 1 Oct 2025
Notice of agreement to exemption from audit of accounts for period ending 31/12/24
Submitted on 1 Oct 2025
Registration of charge 132662530004, created on 17 July 2025
Submitted on 22 Jul 2025
Satisfaction of charge 132662530001 in full
Submitted on 22 Jul 2025
Satisfaction of charge 132662530002 in full
Submitted on 22 Jul 2025
Registration of charge 132662530003, created on 17 July 2025
Submitted on 22 Jul 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year